Lexeo Therapeutics, Inc. (Nasdaq: LXEO), a clinical stage genetic medicine company dedicated to pioneering treatments for genetically defined cardiovascular diseases and APOE4-associated Alzheimer’s ...

InMed Pharmaceuticals Inc. (NASDAQ: INM) ("InMed" or the "Company"), a pharmaceutical company focused on developing a ...

IBN ? Annovis Bio Inc. ("Annovis" or the "Company"), a late-stage clinical drug platform company developing transformative therapies for neurodegenerative disorders such as Alzheimer's disease (AD) ...

Utilising genetic information responsibly allows people to understand the uncertain waters of Alzheimer's with both knowledge and hope; ready to confront challenges together. Here’s why genetic testin ...

Listen to episode nine, “Executing Clinical Research in Dementia with Lewy Bodies (DLB)” on the Conversations tab of the Cognition website. This conversation is presented in 3 Chapters: 1) Comparing ...

This study highlights the efficacy of home-based tDCS in treating major depressive disorder, with significant improvements in ...

Angelini Pharma, Cureverse enter exclusive global option agreement to develop & commercialize innovative brain health asset, CV-01: Rome, Italy Tuesday, October 22, 2024, 17:00 Hr ...

Dominion Lending Centres Inc. ("DLCG" or the "Corporation") is pleased to announce that it will release its third quarter financial results for the three and nine months ended September 30, 2024, on ...

Do you know a conference you think we should list? Let us know by sending us an email with the details to conferences@alzforum.org.

SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company and leader in infectious diseases, ...